Portolan Capital Management LLC Buys 137,458 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Portolan Capital Management LLC increased its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 243.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 193,991 shares of the company's stock after purchasing an additional 137,458 shares during the quarter. Portolan Capital Management LLC owned about 0.69% of Establishment Labs worth $8,937,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. R Squared Ltd acquired a new position in Establishment Labs during the 4th quarter worth $36,000. KLP Kapitalforvaltning AS acquired a new position in shares of Establishment Labs during the fourth quarter valued at $161,000. Handelsbanken Fonder AB boosted its holdings in Establishment Labs by 32.3% in the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after acquiring an additional 2,000 shares during the last quarter. HighTower Advisors LLC increased its position in Establishment Labs by 32.5% in the third quarter. HighTower Advisors LLC now owns 10,311 shares of the company's stock worth $446,000 after purchasing an additional 2,529 shares during the period. Finally, SkyView Investment Advisors LLC raised its holdings in Establishment Labs by 30.5% during the 3rd quarter. SkyView Investment Advisors LLC now owns 12,000 shares of the company's stock worth $519,000 after purchasing an additional 2,805 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company's stock.

Establishment Labs Trading Up 4.2 %

Shares of ESTA stock traded up $1.27 on Friday, reaching $31.45. The company had a trading volume of 558,088 shares, compared to its average volume of 453,840. The company has a 50-day moving average of $36.56 and a 200-day moving average of $39.72. Establishment Labs Holdings Inc. has a 12 month low of $26.56 and a 12 month high of $60.12. The stock has a market cap of $907.21 million, a PE ratio of -12.19 and a beta of 0.77. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. On average, equities analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ESTA. Needham & Company LLC initiated coverage on shares of Establishment Labs in a research note on Monday, April 14th. They issued a "hold" rating on the stock. Stephens restated an "overweight" rating and issued a $52.00 price objective on shares of Establishment Labs in a report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, Establishment Labs has an average rating of "Moderate Buy" and a consensus target price of $57.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.